Zobrazeno 1 - 10
of 228
pro vyhledávání: '"Wj, Storkus"'
Autor:
Markus Maeurer, Sm, Gollin, Wj, Storkus, Swaney W, Karbach J, Martin D, Castelli C, Salter R, Knuth A, Mt, Lotze
Publikováno v:
Europe PubMed Central
Specific CD8(+) CTL recognition of melanoma requires expression of MHC class I molecules as well as melanoma-associated peptide epitopes. Human melanoma cells may escape immune recognition by a variety of means, including global or allelic down-regul
Publikováno v:
Scopus-Elsevier
Markus Maeurer
Europe PubMed Central
CIÊNCIAVITAE
Markus Maeurer
Europe PubMed Central
CIÊNCIAVITAE
Several antigens, including the products encoded by the genes MAGE-1 and MAGE-3, are recognized on human melanoma cells by HLA-A1, HLA-A2, or HLA-Cw*1601*-restricted T cells on autologous or HLA-matched melanoma cell lines. T-cell recognition of natu
Publikováno v:
Europe PubMed Central
Using a newly described pH 3.3 acid elution technique, peptides were extracted by denaturation of class I molecules on the surface of human melanomas. HPLC fractionation of this material revealed six T cell epitopes (termed P1-P6) recognized by HLA-A
Autor:
Tahara H, laurence ZITVOGEL, Wj, Storkus, Hj, Zeh, Tg, Mckinney, Rd, Schreiber, Gubler U, Pd, Robbins, Mt, Lotze
Publikováno v:
Europe PubMed Central
Our recent studies using IL-12 protein or fibroblasts genetically engineered to secrete IL-12 have demonstrated profound antitumor effects of IL-12 in murine models. The antitumor effects of local, high level IL-12 expression were examined using a re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::b01143ef9e9e588d1d810bbae2529d61
http://europepmc.org/abstract/med/7759882
http://europepmc.org/abstract/med/7759882
Autor:
Mazzocchi A, Wj, Storkus, Traversari C, Tarsini P, Markus Maeurer, Rivoltini L, Vegetti C, Belli F, Anichini A, Parmiani G, Castelli C
Publikováno v:
Scopus-Elsevier
CIÊNCIAVITAE
Europe PubMed Central
ResearcherID
Markus Maeurer
CIÊNCIAVITAE
Europe PubMed Central
ResearcherID
Markus Maeurer
The molecular characterization of melanoma-associated Ags allowed the definition of several HLA class I-presented peptides recognized by T cells. However, no HLA-A3.1-restricted melanoma epitopes have been identified to date. To gain insight into the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff255594eff3240a972e9614d5a615b6
http://www.scopus.com/inward/record.url?eid=2-s2.0-0030267510&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-0030267510&partnerID=MN8TOARS
Publikováno v:
Europe PubMed Central
Markus Maeurer
Markus Maeurer
The function and activation requirements for gamma delta T cells residing in the human intestine are still poorly defined. We have established two gamma delta + T cell tumor-infiltrating lymphocyte (TIL) lines derived from a primary colorectal cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::3200cb5982e1a1df1fbba722e95c4524
http://europepmc.org/abstract/med/8696008
http://europepmc.org/abstract/med/8696008
Publikováno v:
Europe PubMed Central
We studied the T-cell receptor alpha chain and beta chain variable region usage in HLA-A2-restricted and melanoma-specific T lymphocytes and correlated such T-cell receptor usage with HLA-A2-presented peptide-specific T-cell recognition.Tumor-infiltr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::28a6debb9cefb27e9890b48b3de4a07e
http://europepmc.org/abstract/med/9166469
http://europepmc.org/abstract/med/9166469
Publikováno v:
Europe PubMed Central
IL-12 is a heterodimeric cytokine produced by macrophages, mitogen stimulated- or EBV infected-B lymphocytes, keratinocytes, and probably dendritic cells, with important immunoregulatory functions in vitro and in vivo. It directly stimulates activate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::54d4f58410a7b436e3da4a8d6ddfcfd2
http://europepmc.org/abstract/med/7636204
http://europepmc.org/abstract/med/7636204
Autor:
Dong B; Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, New York.; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York., Obermajer N; Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania., Tsuji T; Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, New York., Matsuzaki J; Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, New York., Bonura CM; Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, New York., Sander C; Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania., Withers H; Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, New York., Long MD; Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, New York., Chavel C; Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, New York., Olejniczak SH; Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, New York., Minderman H; Flow and Immune Analysis Shared Resource, Roswell Park Comprehensive Cancer Center, Buffalo, New York., Kirkwood JM; Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania., Edwards RP; Department of OB-GYN, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania., Storkus WJ; Department of Dermatology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.; Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania., Romero P; University of Lausanne and Ludwig Institute for Cancer Research, Lausanne, Switzerland., Kalinski P; Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, New York.; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York.; Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.; Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
Publikováno v:
Cancer immunology research [Cancer Immunol Res] 2024 Oct 01; Vol. 12 (10), pp. 1421-1437.
Autor:
Taylor JL; Departments of Dermatology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA., Kokolus KM; Departments of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14203, USA., Basse PH; Departments of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14203, USA., Filderman JN; Departments of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA., Cosgrove CE; Departments of Dermatology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA., Watkins SC; Departments of Cell Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA., Gambotto A; Departments of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA., Lowe DB; Department of Immunotherapeutics and Biotechnology, Jerry H. Hodge School of Pharmacy, Texas Tech University Health Sciences Center, Abilene, TX 79601, USA., Edwards RP; Departments of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA.; UPMC Hillman Cancer Center, Pittsburgh, PA 15213, USA., Kalinski P; Departments of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14203, USA.; Departments of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA.; Departments of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA.; UPMC Hillman Cancer Center, Pittsburgh, PA 15213, USA., Storkus WJ; Departments of Dermatology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA.; Departments of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14203, USA.; UPMC Hillman Cancer Center, Pittsburgh, PA 15213, USA.; Departments of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA.; Departments of Bioengineering, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA.; W1151 Thomas E. Starzl Biomedical Sciences Tower, 200 Lothrop Street, Pittsburgh, PA 15213, USA.
Publikováno v:
Vaccines [Vaccines (Basel)] 2024 Jul 15; Vol. 12 (7). Date of Electronic Publication: 2024 Jul 15.